Evan Darwin1, Marjana Tomic-Canic1. 1. Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1600 NW 10th Ave., RMSB 2023, Miami, FL, 33136, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to raise awareness, examine the challenges faced by wound care researchers and explore opportunities for potential improvements. RECENT FINDINGS: Chronic wounds are associated with significant morbidity and mortality, and they represent a major medical and financial burden. Despite this, no new therapy has received FDA efficacy approval for the treatment of chronic wounds since 1997. Previous preclinical studies using animal models did not translate to human wounds due to inherent limitations of experimental models, variability in assessment methods and overall experimental design. Clinical trials continued to be challenged by the balance of the inclusion and exclusion criteria, the high cost and time expenditure of the trials, and the constraint of a single FDA-acceptable outcome of complete wound closure. SUMMARY: Wound research faces multiple challenges in both pre-clinical and clinical research that slowed progress and development of efficacious therapies. Solutions to such challenges will provide new opportunities for improved study design in the future.
PURPOSE OF REVIEW: The purpose of this review is to raise awareness, examine the challenges faced by wound care researchers and explore opportunities for potential improvements. RECENT FINDINGS: Chronic wounds are associated with significant morbidity and mortality, and they represent a major medical and financial burden. Despite this, no new therapy has received FDA efficacy approval for the treatment of chronic wounds since 1997. Previous preclinical studies using animal models did not translate to human wounds due to inherent limitations of experimental models, variability in assessment methods and overall experimental design. Clinical trials continued to be challenged by the balance of the inclusion and exclusion criteria, the high cost and time expenditure of the trials, and the constraint of a single FDA-acceptable outcome of complete wound closure. SUMMARY: Wound research faces multiple challenges in both pre-clinical and clinical research that slowed progress and development of efficacious therapies. Solutions to such challenges will provide new opportunities for improved study design in the future.
Entities:
Keywords:
Chronic Wounds; Clinical Trials; Research Study Design; Translational Medical Research
Authors: M C Robson; T J Phillips; V Falanga; D J Odenheimer; L C Parish; J L Jensen; D L Steed Journal: Wound Repair Regen Date: 2001 Sep-Oct Impact factor: 3.617
Authors: M C Robson; L G Phillips; A Thomason; B W Altrock; P C Pence; J P Heggers; A F Johnston; T P McHugh; M S Anthony; L E Robson Journal: Ann Plast Surg Date: 1992-09 Impact factor: 1.539
Authors: Harold Brem; Olivera Stojadinovic; Robert F Diegelmann; Hyacinth Entero; Brian Lee; Irena Pastar; Michael Golinko; Harvey Rosenberg; Marjana Tomic-Canic Journal: Mol Med Date: 2007 Jan-Feb Impact factor: 6.354
Authors: Olivera Stojadinovic; Irena Pastar; Sasa Vukelic; My G Mahoney; Donna Brennan; Agata Krzyzanowska; Michael Golinko; Harold Brem; Marjana Tomic-Canic Journal: J Cell Mol Med Date: 2008-03-28 Impact factor: 5.310
Authors: Shirin Nour; Nafiseh Baheiraei; Rana Imani; Mohammad Khodaei; Akram Alizadeh; Navid Rabiee; S Mohammad Moazzeni Journal: J Mater Sci Mater Med Date: 2019-10-19 Impact factor: 3.896
Authors: Maximillian A Weigelt; Hadar A Lev-Tov; Marjana Tomic-Canic; W David Lee; Ryan Williams; David Strasfeld; Robert S Kirsner; Ira M Herman Journal: Adv Wound Care (New Rochelle) Date: 2021-07-21 Impact factor: 4.730
Authors: Andrew P Sawaya; Ivan Jozic; Rivka C Stone; Irena Pastar; Andjela N Egger; Olivera Stojadinovic; George D Glinos; Robert S Kirsner; Marjana Tomic-Canic Journal: JCI Insight Date: 2019-12-05